@pom looks like it's immunotherapy. Maybe it could complement the TKIs? Like what TC was referencing in combo treatments. But for now, it looks like Keytruda (pembrolizumab) is in PI and used when nothing else works.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.